Rhythm Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. 

CEO
David P. Meeker
CEODavid P. Meeker
Employees
283
Employees283
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2008
Founded2008
Employees
283
Employees283

RYTM Key Statistics

Market cap
4.26B
Market cap4.26B
Price-Earnings ratio
-23.77
Price-Earnings ratio-23.77
Dividend yield
Dividend yield
Average volume
699.51K
Average volume699.51K
High today
High today
Low today
Low today
Open price
$64.81
Open price$64.81
Volume
0.00
Volume0.00
52 Week high
$69.89
52 Week high$69.89
52 Week low
$40.46
52 Week low$40.46

RYTM News

TipRanks 21h
Rhythm Pharmaceuticals Advances Setmelanotide Study for Prader-Willi Syndrome

Rhythm Pharmaceuticals ((RYTM)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at...

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own RYTM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.